A company in Lesotho has become the first in Africa to receive a licence to sell medical cannabis to the EU.
The country’s top medical cannabis producer, MG Health announced it had met the EU’s good manufacturing practice (GMP) standards, allowing it to export cannabis flower, oil and extracts as an active pharmaceutical ingredient.
It will export its first batch to Germany later this year.
The GMP guidelines are the minimum requirements a manufacturer or producer must meet to ensure products are safe and of a consistent high quality. They are used to control the licensing for sale of food and pharmaceutical and medical products.
The company is optimistic accreditation will open doors to business with more EU countries and other international markets. It has already received inquiries from France, the UK and Australia.